Clinical Trial Update: Serotonin Selective Reuptake Inhibitor Treatment of Dual Diagnosis Post-traumatic Stress Disorder and Alcohol Problems [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating a serotonin reuptake inhibitor for co-occurring post-traumatic stress disorder and alcohol use disorder; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Post-traumatic Stress Disorder

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: PTSD, Alcohol Use Disorder | Phase 4 | Status: COMPLETED | Results posted: 2018-02-27